Science & Enterprise logo
Science for business people. Enterprise for scientists.
  • Memorial Day 2014

    26 May 2014. Today is Memorial Day in the U.S., and Science & Enterprise is observing the holiday. We will return to our regular postings tomorrow. *     *     *

  • Industrial Scale Graphene Production Process Devised

    23 May 2014. Engineers at University of Michigan, Massachusetts Institute of Technology, and glass manufacturer Guardian Industries developed a process for producing graphene that overcomes many of the obstacles preventing industrial-scale production of this material. The findings of a research team led by MIT’s John Hart and Guardian’s Vijayen Veerasamy appear online today in the…

  • Genetic Blood Transfusion Diagnostic Approved by FDA

    23 May 2014. The U.S. Food and Drug Administration approved a molecular diagnostic test to help determine genetic compatibility for blood transfusions, a particular need for people requiring frequent transfusions. The PreciseType HEA Molecular BeadChip Test is made by BioArray Solutions, a subsidiary of Immucor, a developer of diagnostics for transplants and transfusions in Norcross,…

  • Diagnostic Software Developed to Analyze Video for Autism

    22 May 2014. Computer scientists and medical researchers at Duke University in North Carolina developed software that uses computer vision to analyze video of an infant’s behavior for signs of autism spectrum disorder. The team from the lab of Duke computer engineering professor Guillermo Sapiro — with colleagues from Duke, University of Minnesota, and University…

  • Pfizer, Biotech to Partner on Brown Fat Cell Research

    22 May 2014. BioRestorative Therapies Inc. in Jupiter, Florida and the pharmaceutical company Pfizer Inc. in New York are conducting a joint study of human brown fat tissue and cell lines, to discover more about their use as a platform for therapies for type 2 diabetes and obesity. Financial and intellectual property aspects of the…

  • Engineered Microbes Created to Clean Biodiesel Waste

    21 May 2014. Microbiologists at Michigan State University in East Lansing created a process with two types of genetically-engineered bacteria that work together to clean up the waste water in the production of biodiesel, and generate ethanol as a byproduct. The team led by Michigan State’s Gemma Reguera published its findings online earlier this month…

  • Students Invent Germ-Killing Catheter, Start Company

    21 May 2014. Five medical and engineering students at University of Utah in Salt Lake City invented a new type of catheter that emits high-intensity light killing bacteria before they cause an infection in the patient. The students also formed a new company, Veritas Medical LLC in Salt Lake City to take the invention to…

  • Patent Awarded for Spinal Disc Regeneration Technology

    20 May 2014. Techniques for regrowing new spinal disc cartilage tissue in the body from a person’s own skin cells received a patent from the U.S. Patent and Trademark Office. Patent number 8,728,495 was awarded today to inventors Lionel Sevrain and Sylvie Sevrain-Verdier and assigned to SpinalCyte LLC in Houston. Sevrain and Sevrain-Verdier are principals…

  • Wireless Power System Invented for Miniaturized Implants

    20 May 2014. Engineers and medical researchers at Stanford University in California designed a wireless system that can transfer electric power deep inside the body for miniaturized implants and other therapies. The work of a team led by electrical engineering professor Ada Poon was published online yesterday in Proceedings of the National Academy of Sciences (paid…

  • Engineered Antibody Given FDA Breakthrough Tag for Myeloma

    19 May 2014. Bristol-Myers Squibb in New York says its engineered antibody elotuzumab received a breakthrough therapy designation from the U.S. Food and Drug Administration to treat multiple myeloma, when used with two other cancer drugs. Elotuzumab is being developed by Bristol-Myers Squibb and AbbVie, in North Chicago, Illinois. Multiple myeloma is a progressive cancer…